Nevro (NVRO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

NVRO Nevro

Watchlist

4.125
-0.135-3.17%

Trading Dec 4 14:16 ET

154.57MMarket Cap-2205P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wells Fargo Upgrades Nevro(NVRO.US) to Hold Rating, Cuts Target Price to $5
Moomoo NewsDec 3 06:33 ET · Ratings
Express News | Wells Fargo Reinstates Equal-Weight on Nevro, Announces $5 Price Target
BenzingaDec 3 06:32 ET
Nevro Corp: Hold Rating Amid Market Challenges and Strategic Uncertainty
TipRanksDec 3 05:55 ET
Nevro Resumed With an Equal Weight at Wells Fargo
TipRanksDec 3 05:50 ET
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Seeking AlphaDec 2 16:12 ET
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
BenzingaDec 2 14:29 ET

Comments

Trytosaveabit

Nov 12 06:07

Update

$Nevro (NVRO.US)$ Reuters
6 mins ago
Nevro's Hfx Iq™ Spinal Cord Stimulation With AI Technology Receives Ce Mark Certification in Europe, Increasing Product Expansion Globally

Stock_Drift

Nov 11 16:19

After Hours Ticks. 5:18pm

$Impact BioMedical (IBO.US)$ $Adicet Bio (ACET.US)$ $Zoomcar Holdings (ZCAR.US)$ $Ryde Group (RYDE.US)$ $Foresight Autonomous (FRSX.US)$ $Check-Cap (CHEK.US)$ $Nvni Group (NVNI.US)$ $Bridger Aerospace (BAER.US)$ $Taoping (TAOP.US)$ $Scienjoy (SJ.US)$ $Nevro (NVRO.US)$ $Taysha Gene Therapies (TSHA.US)$ $MultiMetaVerse (MMV.US)$ $XBP Europe Holdings (XBP.US)$

Jaguar8

Sep 24 07:02

NEWS

$Nevro (NVRO.US)$
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
Nevro Corp. (NYSE: NVRO) has announced the FDA approval and market release of HFX iQ™ with HFX AdaptivAI™, an AI-driven spinal cord stimulation (SCS) system for chronic pain management. This technology leverages insights from over 100,000 patients and more than 100 million data points to provide personalized, responsive pain relief in real time.
Key features of HFX Adaptiv...

Newbee4

Aug 8 06:22

Do you have any thoughts on this?

$Nevro (NVRO.US)$ @Trytosaveabit

Moomoo AI

Feb 25 07:35

Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.

Benign Growth For Nevro Corp. (NYSE:NVRO) Underpins Its Share Price

Heat List

Overall

No Data